Scroll To Top
News

Many HAART Patients Do Not Achieve High CD4 Counts

Many HAART Patients Do Not Achieve High CD4 Counts

Coverx150_52

One of the first long-term studies on the effects of highly active antiretroviral therapy shows that only about 39% of people who began therapy between 1996 and 1997 and stuck to it for four years were able to achieve a CD4-cell count above 500. The study, published in the October 13 edition of Archives of Internal Medicine, also shows that 15.6% of the 2,235 participants never posted a CD4 count above 200, an AIDS-defining threshold. Those who did achieve CD4 counts above 500 after four years were more likely to have had higher nadir and baseline CD4 levels and a more sustained reduction in viral loads than those who did not reach the 500-cell mark.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

Bob Adams

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.